Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

125.3  -0.3 (-0.24%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 55 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BIM had positive earnings in the past year.
BIM had a positive operating cash flow in the past year.
Each year in the past 5 years BIM has been profitable.
In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

BIM has a better Return On Assets (7.49%) than 78.18% of its industry peers.
BIM has a better Return On Equity (10.28%) than 72.73% of its industry peers.
The Return On Invested Capital of BIM (9.33%) is better than 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is in line with the industry average of 8.22%.
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROIC 9.33%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM has a Profit Margin of 10.86%. This is in the better half of the industry: BIM outperforms 69.09% of its industry peers.
BIM's Profit Margin has been stable in the last couple of years.
BIM has a Operating Margin of 14.79%. This is in the better half of the industry: BIM outperforms 70.91% of its industry peers.
BIM's Operating Margin has improved in the last couple of years.
BIM's Gross Margin of 55.66% is in line compared to the rest of the industry. BIM outperforms 47.27% of its industry peers.
BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
BIM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BIM has been reduced compared to a year ago.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 7.10. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
BIM's Altman-Z score of 7.10 is amongst the best of the industry. BIM outperforms 90.91% of its industry peers.
The Debt to FCF ratio of BIM is 1.53, which is an excellent value as it means it would take BIM, only 1.53 years of fcf income to pay off all of its debts.
BIM has a Debt to FCF ratio of 1.53. This is amongst the best in the industry. BIM outperforms 85.45% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BIM is not too dependend on debt financing.
BIM has a better Debt to Equity ratio (0.08) than 85.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 7.1
ROIC/WACC1.21
WACC7.74%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.20 indicates that BIM has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.20, BIM is doing good in the industry, outperforming 65.45% of the companies in the same industry.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM's Quick ratio of 1.29 is fine compared to the rest of the industry. BIM outperforms 61.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
The Revenue has been growing by 8.27% on average over the past years. This is quite good.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

The Earnings Per Share is expected to grow by 13.37% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.46, the valuation of BIM can be described as expensive.
67.27% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.04, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 27.02 indicates a quite expensive valuation of BIM.
The rest of the industry has a similar Price/Forward Earnings ratio as BIM.
BIM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.64.
Industry RankSector Rank
PE 32.46
Fwd PE 27.02
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.45% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
63.64% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 46.13
EV/EBITDA 16.54
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
BIM's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.61
PEG (5Y)2.98
EPS Next 2Y16.12%
EPS Next 3Y15.21%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is a higher than the industry average which is at 2.07.
Compared to an average S&P500 Dividend Yield of 2.35, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

23.18% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (7/25/2025, 7:00:00 PM)

125.3

-0.3 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)11-03 2025-11-03
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.83B
Analysts75.29
Price Target127.5 (1.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 32.46
Fwd PE 27.02
P/S 3.73
P/FCF 46.13
P/OCF 22.22
P/B 3.53
P/tB 4.97
EV/EBITDA 16.54
EPS(TTM)3.86
EY3.08%
EPS(NY)4.64
Fwd EY3.7%
FCF(TTM)2.72
FCFY2.17%
OCF(TTM)5.64
OCFY4.5%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.61
PEG (5Y)2.98
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROCE 12.7%
ROIC 9.33%
ROICexc 9.83%
ROICexgc 13.6%
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
FCFM 8.08%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA 0.39
Cap/Depr 106.34%
Cap/Sales 8.69%
Interest Coverage 250
Cash Conversion 73.01%
Profit Quality 74.39%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 7.1
F-Score7
WACC7.74%
ROIC/WACC1.21
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.07%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%